Skip to main content
. 2013 Nov 4;112(8):1188–1200. doi: 10.1111/bju.12363

Table 2.

Graded responder analysis: PP population

Transdermal testosterone Enclomiphene citrate 25 mg Enclomiphene citrate 12.5 mg Enclomiphene citrate 6.25 mg
N = 13 N = 12 n = 7 n = 12
Any increase in total testosterone, n (%) 13 (100) 12 (100) 7 (100) 9 (75)
 CTTmean >300 ng/dL, n (%) 11 (85) 12 (100) 5 (71) 7 (58)
 CTTmean >350 ng/dL, n (%) 11 (85) 12 (100) 4 (57) 6 (50)
 CTTmean >400 ng/dL, n (%) 10 (77) 12 (100) 3 (43) 5 (42)
 CTTmean >500 ng/dL, n (%) 6 (46) 8 (67) 3 (43) 3 (25)